MedTrace Logo

A Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets

NCT00879346 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2009-10-23

No results posted yet for this study

Summary

Phase I, randomised, open label, 3-period crossover study in healthy male subjects to investigate the effect of food on the pharmacokinetics of AZD8931 and to investigate the safety and tolerability of AZD8931.

Conditions

  • Healthy

Interventions

DRUG

AZD8931

160mg oral single dose (4 x 40mg tablets)

Sponsors & Collaborators

Principal Investigators

  • Emeline Ramos, MD · AstraZeneca, Clinical Pharamcology Unit, Alderley Park

  • Mary Stuart, MD · AstraZeneca

Study Design

Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Completion
2009-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00879346 on ClinicalTrials.gov